Abiopharma

🔍 Quist Adam George (Director)

Company: SECURITY NATIONAL FINANCIAL CORP (SNFCA)

Report Date: 2026-04-18

Detailed Transactions and Holdings:

• Acquired 8,934 shares of Class A Common Stock at $9.86 per share (Direct)
  Date: 2026-04-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,942.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 15,901 shares of Employee Stock Option (right to buy) at $4.32 per share (Derivative)
  Date: 2016-12-02 | Code: A | Expires: 2026-12-02 | Exercise: 2017-03-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
• Acquired 22,716 shares of Employee Stock Option (right to buy) at $3.27 per share (Derivative)
  Date: 2017-12-01 | Code: A | Expires: 2027-12-01 | Exercise: 2018-03-01 | equity_swap_involved: 0 | shares_owned_after: 22,716.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 28,846 shares of Employee Stock Option (right to buy) at $3.76 per share (Derivative)
  Date: 2018-11-30 | Code: A | Expires: 2028-11-30 | Exercise: 2019-02-28 | equity_swap_involved: 0 | shares_owned_after: 51,562.00 | transaction_form_type: 4 | Footnotes: F5
• Acquired 48,076 shares of Employee Stock Option (right to buy) at $3.91 per share (Derivative)
  Date: 2019-12-06 | Code: A | Expires: 2029-12-06 | Exercise: 2020-03-06 | equity_swap_involved: 0 | shares_owned_after: 99,638.00 | transaction_form_type: 4 | Footnotes: F6
• Acquired 45,787 shares of Employee Stock Option (right to buy) at $2.84 per share (Derivative)
  Date: 2020-03-27 | Code: A | Expires: 2030-03-27 | Exercise: 2020-06-27 | equity_swap_involved: 0 | shares_owned_after: 145,425.00 | transaction_form_type: 4 | Footnotes: F7
• Acquired 72,931 shares of Employee Stock Option (right to buy) at $7.02 per share (Derivative)
  Date: 2021-12-03 | Code: A | Expires: 2031-12-03 | Exercise: 2022-03-03 | equity_swap_involved: 0 | shares_owned_after: 218,356.00 | transaction_form_type: 4 | Footnotes: F8
• Acquired 92,610 shares of Employee Stock Option (right to buy) at $5.56 per share (Derivative)
  Date: 2022-12-02 | Code: A | Expires: 2032-12-02 | Exercise: 2023-03-02 | equity_swap_involved: 0 | shares_owned_after: 310,966.00 | transaction_form_type: 4 | Footnotes: F9
• Acquired 88,200 shares of Employee Stock Option (right to buy) at $7.21 per share (Derivative)
  Date: 2023-12-01 | Code: A | Expires: 2033-12-01 | Exercise: 2024-03-01 | equity_swap_involved: 0 | shares_owned_after: 399,166.00 | transaction_form_type: 4 | Footnotes: F10
• Acquired 7,298 shares of Employee Stock Option (right to buy) at $13.67 per share (Derivative)
  Date: 2024-12-06 | Code: A | Expires: 2029-12-06 | Exercise: 2025-03-06 | equity_swap_involved: 0 | shares_owned_after: 406,464.00 | transaction_form_type: 4 | Footnotes: F11
• Acquired 76,703 shares of Employee Stock Option (right to buy) at $12.43 per share (Derivative)
  Date: 2024-12-06 | Code: A | Expires: 2034-12-06 | Exercise: 2025-03-06 | equity_swap_involved: 0 | shares_owned_after: 483,167.00 | transaction_form_type: 4 | Footnotes: F12
• Acquired 10,657 shares of Employee Stock Option (right to buy) at $9.38 per share (Derivative)
  Date: 2025-12-05 | Code: A | Expires: 2030-12-05 | Exercise: 2026-03-05 | equity_swap_involved: 0 | shares_owned_after: 493,824.00 | transaction_form_type: 4 | Footnotes: F13
• Acquired 289,343 shares of Employee Stock Option (right to buy) at $8.53 per share (Derivative)
  Date: 2025-12-05 | Code: A | Expires: 2035-12-05 | Exercise: 2026-03-05 | equity_swap_involved: 0 | shares_owned_after: 783,167.00 | transaction_form_type: 4 | Footnotes: F14

Footnotes:

• F1: Does not include 22,143 shares of Class A Common Stock owned indirectly by the reporting person in the Deferred Compensation Plan.
• F2: Does not include 28,726 shares of Class A Common Stock owned indirectly by the reporting person in the 401(k) Retirement Savings Plan.
• F3: This option was granted on December 2, 2016 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
• F4: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
• F5: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
• F6: This option was granted on December 6, 2019 as an option to purchase either 35,000 shares of Class A Common Stock or 35,000 shares of Class C Common Stock at an exercise price of $5.46 per share. This option reflects the reporting person's election to have an option for 35,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
• F7: This option was granted on March 27, 2020 as an option to purchase either 35,000 shares of Class A Common Stock or 35,000 shares of Class C Common Stock at an exercise price of $3.76 per share. This option reflects the reporting person's election to have an option for 35,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
• F8: This option was granted on December 3, 2021 as an option to purchase either 60,000 shares of Class A Common Stock or 60,000 shares of Class C Common Stock at an exercise price of $8.62 per share. This option reflects the reporting person's election to have an option for 60,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
• F9: This option was granted on December 2, 2022 as an option for either 80,000 shares of Class A Common Stock or 80,000 shares of Class C Common Stock at an exercise price of $6.48 per share. This option reflects the reporting person's election to have an option for 80,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025.
• F10: This option was granted on December 1, 2023 as an option for either 80,000 shares of Class A Common Stock or 80,000 shares of Class C Common Stock at an exercise price of $7.99 per share. This option reflects the reporting person's election to have an option for 80,000 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025.
• F11: This option was granted on December 6, 2024 as an option for either 6,950 shares of Class A Common Stock or 6,950 shares of Class C Common Stock at an exercise price of $14.39 per share. This option reflects the reporting person's election to have an option for 6,950 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
• F12: This option was granted on December 6, 2024 as an option for either 73,050 shares of Class A Common Stock or 73,050 shares of Class C Common Stock at an exercise price of $13.08 per share. This option reflects the reporting person's election to have an option for 73,050 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
• F13: This option was granted on December 5, 2025 as an option for either 10,657 shares of Class A Common Stock or 10,657 shares of Class C Common Stock at an exercise price of $9.38 per share. This option reflects the reporting person's election to have an option for 10,657 Class A Common Stock. These options vest quarterly in equal installments, beginning on March 5, 2026.
• F14: This option was granted on December 5, 2025 as an option for either 289,343 shares of Class A Common Stock or 289,343 shares of Class C Common Stock at an exercise price of $8.53 per share. This option reflects the reporting person's election to have an option for 289,343 Class C Common Stock. These options vest quarterly in equal installments, beginning on March 5, 2026.